Loading organizations...
Loading organizations...
Radioactive molecular imaging and nuclear drug transformation platform.
WuXi Bo Rui Biotechnology has raised $43.3M across 1 funding round.
WuXi Bo Rui Biotechnology has raised $43.3M in total across 1 funding round.
WuXi Bo Rui Biotechnology has raised $43.3M in total across 1 funding round.
WuXi Bo Rui Biotechnology's investors include Hongshan Capital Group (Sequoia Capital China).
WuXi Bo Rui Biotechnology has raised $43.3M across 1 funding round. Most recently, it raised $43.3M Series B in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 5, 2022 | $43.3M Series B | Hongshan Capital Group (Sequoia Capital China) |